[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Memantine.]
[J01GA01, streptomycin, Memantine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The metabolism of Succinylcholine can be decreased when combined with Memantine.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01CG01, sulbactam, Memantine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Memantine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Memantine.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Memantine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Memantine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AE05, lurasidone, The therapeutic efficacy of Memantine can be decreased when used in combination with Lurasidone.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Memantine.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A11DA01, thiamine, The serum concentration of Memantine can be increased when it is combined with Thiamine.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Memantine.]
[N05AB08, thioproperazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Thioproperazine.]
[N05AC02, thioridazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Thioridazine.]
[N05AF04, thiothixene, The therapeutic efficacy of Memantine can be decreased when used in combination with Thiothixene.]
[G04BE06, moxisylyte, Memantine may increase the neuromuscular blocking activities of Moxisylyte.]
[N05AL03, tiapride, Memantine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Memantine.]
[S01ED01, timolol, Memantine may increase the bradycardic activities of Timolol.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA12, tobramycin, Memantine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V04CA01, tolbutamide, Memantine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AX02, tramadol, The risk or severity of adverse effects can be increased when Tramadol is combined with Memantine.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Memantine.]
[S01BA05, triamcinolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Memantine.]
[A16AX12, trientine, Memantine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Trifluoperazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AA05, triflupromazine, The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Memantine.]
[D07AC02, fluclorolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluclorolone.]
[N04AA01, trihexyphenidyl, The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Memantine.]
[R03BA07, mometasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Mometasone.]
[A03AA05, trimebutine, The therapeutic efficacy of Trimebutine can be decreased when used in combination with Memantine.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Memantine.]
[C02BA01, trimethaphan, Memantine may increase the neuromuscular blocking activities of Trimethaphan.]
[J01EA01, trimethoprim, The serum concentration of Memantine can be increased when it is combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Memantine.]
[A03BB01, butylscopolamine, The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Memantine.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Memantine.]
[M03AA02, tubocurarine, Memantine may increase the neuromuscular blocking activities of Tubocurarine.]
[R03DX07, roflumilast, Memantine may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Memantine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The serum concentration of Memantine can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Memantine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Memantine can be increased when it is combined with Linagliptin.]
[J05AG05, rilpivirine, The metabolism of Rilpivirine can be decreased when combined with Memantine.]
[S01AA28, vancomycin, Memantine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Memantine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Memantine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Memantine.]
[N06AX09, viloxazine, Memantine may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[B01AA03, warfarin, Memantine may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Memantine.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Memantine can be decreased when used in combination with Zuclopenthixol.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M05BA05, tiludronic acid, Memantine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Memantine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Memantine can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AE04, ziprasidone, The therapeutic efficacy of Memantine can be decreased when used in combination with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Memantine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Memantine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The therapeutic efficacy of Tolterodine can be decreased when used in combination with Memantine.]
[J01DH04, doripenem, Memantine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Memantine may increase the bradycardic activities of Atenolol.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Memantine.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be decreased when used in combination with Memantine.]
[S01FA01, atropine, The therapeutic efficacy of Atropine can be decreased when used in combination with Memantine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Memantine.]
[H02AB11, prednylidene, The therapeutic efficacy of Memantine can be decreased when used in combination with Prednylidene.]
[B03XA04, peginesatide, Memantine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Memantine.]
[G04BD12, mirabegron, Memantine may increase the neuromuscular blocking activities of Mirabegron.]
[L02BB04, enzalutamide, Memantine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[A02AA05, magnesium silicate, Magnesium silicate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02AC02, calcium silicate, Calcium silicate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[H02AA01, aldosterone, The therapeutic efficacy of Memantine can be decreased when used in combination with Aldosterone.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Memantine.]
[D02BA02, octinoxate, Memantine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[N04BD02, rasagiline, Memantine may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Memantine.]
[R06AC06, thonzylamine, The therapeutic efficacy of Thonzylamine can be decreased when used in combination with Memantine.]
[G04BD10, darifenacin, The therapeutic efficacy of Darifenacin can be decreased when used in combination with Memantine.]
[V09IX04, fluorodeoxyglucose F18, Memantine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Memantine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Memantine.]
[A16AX08, teduglutide, Memantine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Memantine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Memantine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Memantine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Memantine.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Memantine.]
[L03AA12, ancestim, Memantine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N04AC01, benztropine, The therapeutic efficacy of Benzatropine can be decreased when used in combination with Memantine.]
[L01EC02, dabrafenib, The serum concentration of Memantine can be increased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01EE01, trametinib, Memantine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Memantine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Memantine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, The serum concentration of Memantine can be increased when it is combined with Dolutegravir.]
[A10BJ03, lixisenatide, Memantine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Memantine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Memantine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Memantine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Memantine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, Memantine may increase the bradycardic activities of Acebutolol.]
[N05CH03, tasimelteon, Memantine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Memantine may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Memantine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Betamethasone.]
[S01ED02, betaxolol, Memantine may increase the bradycardic activities of Betaxolol.]
[V03AB34, fomepizole, Memantine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[A03BA03, hyoscyamine, The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Memantine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Memantine.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[D11AA01, glycopyrronium, The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Memantine.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V04CX03, methacholine, The risk or severity of adverse effects can be increased when Memantine is combined with Methacholine.]
[N04AA02, biperiden, The therapeutic efficacy of Biperiden can be decreased when used in combination with Memantine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Memantine.]
[S03AA06, gentamicin, Memantine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Memantine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EX08, lenvatinib, The serum concentration of Memantine can be increased when it is combined with Lenvatinib.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03AA09, difemerine, The therapeutic efficacy of Difemerine can be decreased when used in combination with Memantine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Memantine.]
[N05AX16, brexpiprazole, The therapeutic efficacy of Memantine can be decreased when used in combination with Brexpiprazole.]
[A06AD03, magnesium peroxide, Magnesium peroxide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AX15, cariprazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Cariprazine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01EC01, acetazolamide, The excretion of Memantine can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V03AB37, idarucizumab, Memantine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Memantine.]
[J02AC05, isavuconazole, The serum concentration of Memantine can be increased when it is combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Memantine.]
[L01XG03, ixazomib, Memantine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Memantine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[N05CA05, aprobarbital, The therapeutic efficacy of Aprobarbital can be decreased when used in combination with Memantine.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02AB06, aloglutamol, Aloglutamol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Memantine.]
[N05BA08, bromazepam, Memantine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Almasilate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02AB03, aluminum phosphate, Aluminium phosphate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be decreased when combined with Memantine.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AA19, bupranolol, Memantine may increase the bradycardic activities of Bupranolol.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Memantine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Memantine.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Memantine.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03CC12, bambuterol, Memantine may increase the neuromuscular blocking activities of Bambuterol.]
[A06AH05, naldemedine, Memantine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Memantine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01HA02, benoxinate, Memantine may increase the neuromuscular blocking activities of Oxybuprocaine.]
[A12AA04, calcium carbonate, Calcium carbonate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R05DB01, benzonatate, Memantine may increase the neuromuscular blocking activities of Benzonatate.]
[P01CA02, benznidazole, Memantine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Memantine may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Memantine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N07AB02, bethanechol, The risk or severity of adverse effects can be increased when Memantine is combined with Bethanechol.]
[J01MA23, delafloxacin, Memantine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Memantine is combined with Acetylcholine.]
[L01BC06, capecitabine, Memantine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Memantine.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AB07, bisoprolol, Memantine may increase the bradycardic activities of Bisoprolol.]
[J05AG03, efavirenz, The metabolism of Efavirenz can be decreased when combined with Memantine.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AA17, bopindolol, Memantine may increase the bradycardic activities of Bopindolol.]
[N04AA11, bornaprine, The therapeutic efficacy of Bornaprine can be decreased when used in combination with Memantine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The therapeutic efficacy of Memantine can be decreased when used in combination with Budesonide.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CA03, butobarbital, The therapeutic efficacy of Butobarbital can be decreased when used in combination with Memantine.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Memantine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[S01EB02, carbachol, The risk or severity of adverse effects can be increased when Memantine is combined with Carbamoylcholine.]
[L02BB05, apalutamide, The serum concentration of Memantine can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, Memantine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03AA03, camylofine, The therapeutic efficacy of Camylofin can be decreased when used in combination with Memantine.]
[C07AG02, carvedilol, Memantine may increase the bradycardic activities of Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Memantine.]
[L04AA37, baricitinib, Memantine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[V03AE10, sodium zirconium cyclosilicate, Sodium zirconium cyclosilicate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01GB14, plazomicin, Memantine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, Memantine may increase the bradycardic activities of Celiprolol.]
[P01BA07, tafenoquine, The serum concentration of Memantine can be increased when it is combined with Tafenoquine.]
[A16AX14, migalastat, Memantine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Stiripentol can be decreased when combined with Memantine.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N01BA04, chloroprocaine, Memantine may increase the neuromuscular blocking activities of Chloroprocaine.]
[D08AE05, chloroxylenol, Memantine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Memantine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Memantine.]
[R03BB08, revefenacin, The therapeutic efficacy of Revefenacin can be decreased when used in combination with Memantine.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07XX05, amifampridine, The risk or severity of adverse effects can be increased when Memantine is combined with Amifampridine.]
[A06AX05, prucalopride, Memantine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Memantine.]
[A09AB04, citric acid, The excretion of Memantine can be decreased when combined with Citric acid.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Memantine.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Memantine.]
[N06BA14, solriamfetol, Memantine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Memantine can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Memantine.]
[H02AB14, cloprednol, The therapeutic efficacy of Memantine can be decreased when used in combination with Cloprednol.]
[H02AB17, cortivazol, The therapeutic efficacy of Memantine can be decreased when used in combination with Cortivazol.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Memantine.]
[N07XX11, pitolisant, Memantine may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Memantine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[H02AB13, deflazacort, The therapeutic efficacy of Memantine can be decreased when used in combination with Deflazacort.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Memantine.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Memantine.]
[N03AX25, cenobamate, The metabolism of Cenobamate can be decreased when combined with Memantine.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M09AX08, golodirsen, Memantine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Memantine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05AD10, lumateperone, The therapeutic efficacy of Memantine can be decreased when used in combination with Lumateperone.]
[H02CA02, osilodrostat, The metabolism of Osilodrostat can be decreased when combined with Memantine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Memantine.]
[R02AA03, dichlorobenzyl alcohol, Memantine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Memantine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C08CA16, clevidipine, Memantine may increase the neuromuscular blocking activities of Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Memantine can be increased when it is combined with Dronedarone.]
[L01EH03, tucatinib, The serum concentration of Memantine can be increased when it is combined with Tucatinib.]
[A03AA08, dihexyverine, The therapeutic efficacy of Dihexyverine can be decreased when used in combination with Memantine.]
[D07XB03, fluprednidene, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluprednidene.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Memantine.]
[G04BD09, trospium, The therapeutic efficacy of Trospium can be decreased when used in combination with Memantine.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V08CA05, mangafodipir, Memantine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Memantine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Memantine.]
[P01BA01, chloroquine, Chloroquine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The serum concentration of Memantine can be increased when it is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Memantine can be decreased when used in combination with Chlorprothixene.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02BA03, choline salicylate, The serum concentration of Memantine can be increased when it is combined with Choline salicylate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AX25, chondroitin sulfates, Memantine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[V03AF12, trilaciclib, The serum concentration of Memantine can be increased when it is combined with Trilaciclib.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Felbamate is combined with Memantine.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03BA03, flunisolide, The therapeutic efficacy of Memantine can be decreased when used in combination with Flunisolide.]
[S02BA08, fluocinolone acetonide, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluocinolone acetonide.]
[N02BG07, flupirtine, Memantine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Memantine.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Memantine.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01XA01, cisplatin, Memantine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Memantine is combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Memantine.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Memantine.]
[V09AB03, ioflupane I-123, Memantine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Memantine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Memantine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AX25, St. John's wort extract, The metabolism of St. John's Wort can be decreased when combined with Memantine.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Memantine.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Memantine.]
[N03AE01, clonazepam, Memantine may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Memantine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, Vonoprazan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Memantine.]
[N05AH02, clozapine, The therapeutic efficacy of Memantine can be decreased when used in combination with Clozapine.]
[J01GB12, arbekacin, Memantine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, Memantine may increase the neuromuscular blocking activities of Cocaine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M03AC05, hexafluorenium, The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Memantine.]
[M04AC01, colchicine, Memantine may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[A03AB10, hexocyclium, The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Memantine.]
[A03BB06, homatropine methylbromide, The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Memantine.]
[J01XB01, colistin, Memantine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02AD04, hydrotalcite, Hydrotalcite may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A04AA03, tropisetron, Memantine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Ifenprodil is combined with Memantine.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03BA08, ciclesonide, The therapeutic efficacy of Memantine can be decreased when used in combination with Ciclesonide.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R06AX27, desloratadine, The therapeutic efficacy of Desloratadine can be decreased when used in combination with Memantine.]
[J05AB14, valganciclovir, Memantine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Memantine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Memantine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Memantine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Memantine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Memantine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05BA10, ketazolam, Memantine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Memantine can be increased when it is combined with Imatinib.]
[A02BC05, esomeprazole, Esomeprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AX09, lamotrigine, The serum concentration of Memantine can be increased when it is combined with Lamotrigine.]
[S01BA03, cortisone, The therapeutic efficacy of Memantine can be decreased when used in combination with Cortisone.]
[N07BC04, lofexidine, Memantine may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02AD02, magaldrate, Magaldrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Magnesium carbonate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03AA04, mebeverine, The therapeutic efficacy of Mebeverine can be decreased when used in combination with Memantine.]
[C07AA14, mepindolol, Memantine may increase the bradycardic activities of Mepindolol.]
[H02AB15, meprednisone, The therapeutic efficacy of Memantine can be decreased when used in combination with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N04AA03, methixene, The therapeutic efficacy of Metixene can be decreased when used in combination with Memantine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The therapeutic efficacy of Memantine can be decreased when used in combination with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Memantine.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Memantine.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Memantine.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07BB05, nalmefene, Memantine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, Memantine may increase the bradycardic activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AX06, nefazodone, Memantine may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Memantine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Memantine.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be decreased when used in combination with Memantine.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Memantine.]
[G04BD08, solifenacin, The therapeutic efficacy of Solifenacin can be decreased when used in combination with Memantine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AA01, desipramine, The serum concentration of Memantine can be increased when it is combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[D07XC02, desoximetasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Desoximetasone.]
[V04CH02, indigo carmine, Memantine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[H02AA03, desoxycorticosterone, The therapeutic efficacy of Memantine can be decreased when used in combination with Desoxycortone.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S03BA01, dexamethasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Dexamethasone.]
[N04AA08, dexetimide, The therapeutic efficacy of Dexetimide can be decreased when used in combination with Memantine.]
[G04BD04, oxybutynin, The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Memantine.]
[A03AA01, oxyphencyclimine, The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Memantine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Memantine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Memantine.]
[P03AC04, permethrin, Memantine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Memantine.]
[R05DA08, pholcodine, Memantine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, The excretion of Memantine can be decreased when combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Memantine.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03AA07, dicyclomine, The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Memantine.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03AB14, pipenzolate, The therapeutic efficacy of Pipenzolate can be decreased when used in combination with Memantine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[D07XC04, diflucortolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Difluocortolone.]
[A03AB11, poldine, The therapeutic efficacy of Poldine can be decreased when used in combination with Memantine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01AA05, digoxin, Memantine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Memantine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V03AB09, dimercaprol, Memantine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R06AB03, dimethindene, The therapeutic efficacy of Dimetindene can be decreased when used in combination with Memantine.]
[M02AX03, dimethyl sulfoxide, Memantine may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G02AD02, dinoprostone, The serum concentration of Memantine can be increased when it is combined with Dinoprostone.]
[R06AA02, diphenhydramine, The serum concentration of Memantine can be increased when it is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The therapeutic efficacy of Memantine can be decreased when used in combination with Dipyridamole.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Memantine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Memantine.]
[S01AX06, resorcinol, Memantine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The serum concentration of Memantine can be increased when it is combined with Disopyramide.]
[N05AX08, risperidone, The therapeutic efficacy of Memantine can be decreased when used in combination with Risperidone.]
[R06AE09, levocetirizine, Memantine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01EB18, ranolazine, The serum concentration of Memantine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03AC12, salmeterol, The serum concentration of Memantine can be increased when it is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Memantine.]
[C01CA04, dopamine, The serum concentration of Memantine can be increased when it is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Memantine.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Memantine.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R06AA09, doxylamine, The therapeutic efficacy of Doxylamine can be decreased when used in combination with Memantine.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Memantine.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Memantine.]
[N05AD08, droperidol, The therapeutic efficacy of Memantine can be decreased when used in combination with Droperidol.]
[A08AA10, sibutramine, Memantine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Memantine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AB13, talinolol, Memantine may increase the bradycardic activities of Talinolol.]
[H01AA01, corticotropin, The therapeutic efficacy of Memantine can be decreased when used in combination with Corticotropin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AA16, tertatolol, Memantine may increase the bradycardic activities of Tertatolol.]
[G04BD01, emepronium, The therapeutic efficacy of Emepronium can be decreased when used in combination with Memantine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AG03, toloxatone, Memantine may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Memantine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[A03AB08, tridihexethyl, The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Memantine.]
[H02CA01, trilostane, The therapeutic efficacy of Memantine can be decreased when used in combination with Trilostane.]
[N04AA12, tropatepine, The therapeutic efficacy of Tropatepine can be decreased when used in combination with Memantine.]
[S01FB02, ephedrine, Memantine may increase the neuromuscular blocking activities of Ephedrine.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Memantine.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01EA01, epinephrine, The serum concentration of Memantine can be increased when it is combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Memantine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AX15, zonisamide, The excretion of Memantine can be decreased when combined with Zonisamide.]
[N05AX11, zotepine, The therapeutic efficacy of Memantine can be decreased when used in combination with Zotepine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Memantine.]
[L03AX05, pidotimod, Memantine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Memantine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G03CA03, estradiol, The serum concentration of Memantine can be increased when it is combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03BA05, fluticasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluticasone.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Memantine.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Memantine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AE03, sertindole, The therapeutic efficacy of Memantine can be decreased when used in combination with Sertindole.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02BA04, nizatidine, Nizatidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R06AX12, terfenadine, The therapeutic efficacy of Terfenadine can be decreased when used in combination with Memantine.]
[P01AX07, trimetrexate, Memantine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The excretion of Memantine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Memantine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Memantine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02BA03, famotidine, Famotidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Memantine.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Memantine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Memantine.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07AX03, cevimeline, The risk or severity of adverse effects can be increased when Memantine is combined with Cevimeline.]
[G04BD02, flavoxate, The therapeutic efficacy of Flavoxate can be decreased when used in combination with Memantine.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J02AX01, flucytosine, Memantine may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[H02AA02, fludrocortisone, The therapeutic efficacy of Memantine can be decreased when used in combination with Fludrocortisone.]
[V03AB25, flumazenil, Memantine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07XB01, flumethasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Flumethasone.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Memantine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Memantine.]
[D07AC08, fluocinonide, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluocinonide.]
[H02AB03, fluocortolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Ethanol is combined with Memantine.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01CB05, fluorometholone, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluorometholone.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Memantine.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Memantine.]
[N05AF01, flupenthixol, The therapeutic efficacy of Memantine can be decreased when used in combination with Flupentixol.]
[N05AB02, fluphenazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluphenazine.]
[N05CD01, flurazepam, The serum concentration of Memantine can be increased when it is combined with Flurazepam.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Memantine.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be decreased when used in combination with Memantine.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AL05, amisulpride, The therapeutic efficacy of Memantine can be decreased when used in combination with Amisulpride.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be decreased when used in combination with Memantine.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C10AB04, gemfibrozil, Memantine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Memantine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Memantine.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Memantine.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Memantine.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Memantine.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Memantine.]
[A10BB07, glipizide, Memantine may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Memantine.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AB09, esmolol, Memantine may increase the bradycardic activities of Esmolol.]
[M01CB04, aurothioglucose, Memantine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Memantine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01EX01, guanethidine, Memantine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AD01, haloperidol, The risk or severity of adverse effects can be increased when Haloperidol is combined with Memantine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Memantine.]
[N05AH04, quetiapine, The therapeutic efficacy of Memantine can be decreased when used in combination with Quetiapine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Memantine.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G03DC01, allylestrenol, Memantine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Memantine.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Memantine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C02DB02, hydralazine, Memantine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Memantine.]
[S02BA01, hydrocortisone, The therapeutic efficacy of Memantine can be decreased when used in combination with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The therapeutic efficacy of Memantine can be decreased when used in combination with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Memantine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, The excretion of Memantine can be decreased when combined with Potassium citrate.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G04BD06, propiverine, The therapeutic efficacy of Propiverine can be decreased when used in combination with Memantine.]
[B05AA07, hetastarch, Memantine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[B05XA08, sodium acetate, Memantine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The excretion of Memantine can be decreased when combined with Sodium citrate.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Memantine.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Memantine.]
[R01AD07, tixocortol, The therapeutic efficacy of Memantine can be decreased when used in combination with Tixocortol.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A11HA07, inositol, Memantine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Memantine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[A03AA30, piperidolate, The therapeutic efficacy of Piperidolate can be decreased when used in combination with Memantine.]
[S01XA28, varenicline, The serum concentration of Memantine can be increased when it is combined with Varenicline.]
[A10BH01, sitagliptin, Memantine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Memantine.]
[R06AE01, buclizine, The therapeutic efficacy of Buclizine can be decreased when used in combination with Memantine.]
[C07AA01, alprenolol, Memantine may increase the bradycardic activities of Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Memantine may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be decreased when combined with Memantine.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AX05, inosine pranobex, Memantine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA24, kanamycin, Memantine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Ketamine is combined with Memantine.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Memantine.]
[H02CA04, levoketoconazole, The serum concentration of Memantine can be increased when it is combined with Levoketoconazole.]
[N05AH03, olanzapine, The therapeutic efficacy of Memantine can be decreased when used in combination with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AG01, labetalol, Memantine may increase the bradycardic activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Memantine.]
[A06AX03, lubiprostone, Memantine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Memantine.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA21, amikacin, Memantine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The serum concentration of Memantine can be increased when it is combined with Amiloride.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AH01, loxapine, The therapeutic efficacy of Memantine can be decreased when used in combination with Loxapine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Memantine.]
[B05XA11, magnesium chloride, Memantine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A12CC10, magnesium oxide, Magnesium oxide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01BA05, pralatrexate, Memantine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The therapeutic efficacy of Maprotiline can be decreased when used in combination with Memantine.]
[C02BB01, mecamylamine, The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Memantine.]
[R06AE05, meclizine, The therapeutic efficacy of Meclizine can be decreased when used in combination with Memantine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA05, pentaerythritol tetranitrate, Memantine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Memantine can be decreased when used in combination with Fluticasone furoate.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Meperidine is combined with Memantine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Memantine.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Memantine.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G04BX16, tiopronin, Memantine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Mesoridazine.]
[N05AX13, paliperidone, The therapeutic efficacy of Memantine can be decreased when used in combination with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Memantine.]
[N06BA03, methamphetamine, Memantine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[A03AB07, methantheline, Methantheline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Memantine.]
[S01EC05, methazolamide, The excretion of Memantine can be decreased when combined with Methazolamide.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L01BA04, pemetrexed, Memantine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Memantine.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Memantine which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Memantine can be increased when it is combined with Methylene blue.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Methylphenidate is combined with Memantine.]
[H02AB04, methylprednisolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Methylprednisolone.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Memantine.]
[A03FA01, metoclopramide, The therapeutic efficacy of Memantine can be decreased when used in combination with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Memantine may increase the bradycardic activities of Metoprolol.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Memantine.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Memantine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Memantine.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AE02, molindone, The therapeutic efficacy of Memantine can be decreased when used in combination with Molindone.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01BD01, amiodarone, The serum concentration of Memantine can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Memantine.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Memantine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Memantine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be decreased when used in combination with Memantine.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Memantine.]
[N06AA17, amoxapine, The therapeutic efficacy of Amoxapine can be decreased when used in combination with Memantine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Memantine.]
[C07AA12, nadolol, Memantine may increase the bradycardic activities of Nadolol.]
[J01CA04, amoxicillin, Memantine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Memantine may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L02BG04, letrozole, The metabolism of Letrozole can be decreased when combined with Memantine.]
[S03AA01, neomycin, Memantine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AX14, iloperidone, The therapeutic efficacy of Memantine can be decreased when used in combination with Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[L03AX16, plerixafor, Memantine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Memantine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Memantine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01CE01, inamrinone, Memantine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C08CA04, nicardipine, The therapeutic efficacy of Nicardipine can be decreased when used in combination with Memantine.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Memantine.]
[C08CA05, nifedipine, Memantine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C01CA03, norepinephrine, The serum concentration of Memantine can be increased when it is combined with Norepinephrine.]
[N06AA10, nortriptyline, The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Memantine.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AA02, opium, Memantine may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AA02, oxprenolol, Memantine may increase the bradycardic activities of Oxprenolol.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A03AB03, oxyphenonium, The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Memantine.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Memantine can be increased when it is combined with Aminohippuric acid.]
[N05AH05, asenapine, The therapeutic efficacy of Memantine can be decreased when used in combination with Asenapine.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Memantine.]
[J04AB30, capreomycin, Memantine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The therapeutic efficacy of Memantine can be decreased when used in combination with Paramethasone.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G04BD11, fesoterodine, The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Memantine.]
[C07AA23, penbutolol, Memantine may increase the bradycardic activities of Penbutolol.]
[J01CE09, penicillin G procaine, Memantine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Pentobarbital can be decreased when combined with Memantine.]
[L01XX08, pentostatin, Memantine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Memantine.]
[N05AB03, perphenazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Memantine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A10BA01, phenformin, The serum concentration of Memantine can be increased when it is combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Memantine.]
[C04AX02, phenoxybenzamine, The serum concentration of Memantine can be increased when it is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A02BC06, dexlansoprazole, Dexlansoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Memantine.]
[S01AE05, levofloxacin, Memantine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01EB01, pilocarpine, The risk or severity of adverse effects can be increased when Memantine is combined with Pilocarpine.]
[N05AG02, pimozide, The therapeutic efficacy of Memantine can be decreased when used in combination with Pimozide.]
[C07AA03, pindolol, Memantine may increase the bradycardic activities of Pindolol.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N06BX03, piracetam, Memantine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[A02BX03, pirenzepine, The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Memantine.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The serum concentration of Memantine can be increased when it is combined with Grepafloxacin.]
[N02CX01, pizotyline, The therapeutic efficacy of Pizotifen can be decreased when used in combination with Memantine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH03, saxagliptin, Memantine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C07AB01, practolol, Memantine may increase the bradycardic activities of Practolol.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Memantine.]
[S03BA02, prednisolone, The therapeutic efficacy of Memantine can be decreased when used in combination with Prednisolone.]
[H02AB07, prednisone, The therapeutic efficacy of Memantine can be decreased when used in combination with Prednisone.]
[N03AA03, primidone, The metabolism of Primidone can be decreased when combined with Memantine.]
[M04AB01, probenecid, The serum concentration of Memantine can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Memantine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Procaine is combined with Memantine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N05AB04, prochlorperazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Prochlorperazine.]
[N04AA04, procyclidine, The therapeutic efficacy of Procyclidine can be decreased when used in combination with Memantine.]
[G03DA04, progesterone, The serum concentration of Memantine can be increased when it is combined with Progesterone.]
[N05AA03, promazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Memantine.]
[C01BC03, propafenone, Memantine may increase the bradycardic activities of Propafenone.]
[A03AB05, propantheline, The therapeutic efficacy of Propantheline can be decreased when used in combination with Memantine.]
[N05AC01, periciazine, The therapeutic efficacy of Memantine can be decreased when used in combination with Periciazine.]
[N05CM06, propiomazine, The therapeutic efficacy of Propiomazine can be decreased when used in combination with Memantine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Memantine.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Memantine.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Memantine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[B01AC09, epoprostenol, Memantine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Memantine.]
[N05AX12, aripiprazole, The therapeutic efficacy of Memantine can be decreased when used in combination with Aripiprazole.]
[N07XX07, dalfampridine, Memantine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[A03AB15, diphemanil, The therapeutic efficacy of Diphemanil can be decreased when used in combination with Memantine.]
[A03AB09, isopropamide, The therapeutic efficacy of Isopropamide can be decreased when used in combination with Memantine.]
[S01FA03, methscopolamine, The therapeutic efficacy of Methscopolamine can be decreased when used in combination with Memantine.]
[N05CA07, talbutal, The therapeutic efficacy of Talbutal can be decreased when used in combination with Memantine.]
[P02CC01, pyrantel, Memantine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[P01AX05, quinacrine, The serum concentration of Memantine can be increased when it is combined with Quinacrine.]
[C01BA01, quinidine, Memantine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The serum concentration of Memantine can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Memantine which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Memantine which could result in a higher serum level.]
[S01FA02, scopolamine, The therapeutic efficacy of Scopolamine can be decreased when used in combination with Memantine.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Memantine.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Memantine.]
[J01GB08, sisomicin, Memantine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Memantine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Memantine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, Memantine may increase the bradycardic activities of Sotalol.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy.]
[D07AC14, methylprednisolone aceponate, The therapeutic efficacy of Memantine can be decreased when used in combination with Methylprednisolone aceponate.]
[R03BB01, ipratropium bromide, The therapeutic efficacy of Ipratropium can be decreased when used in combination with Memantine.]
